The tariff war starts in February with initial estimates ranging from 10%-25%.Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit.The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for...
Continue reading >>[embed]https://vimeo.com/1049295901[/embed]For investors that missed Nvidia’s (NVDA) incredible triple-digit return of 145% in 2024 and the stock’s five-year return of over 2,000%, many feel as though they may have missed the artificial intelligence (AI) boom. The good news is that the AI revolution spans several sectors, from cloud computing and semiconductor manufacturing to software...
Continue reading >>by Market Updates and Alerts 390,000 JOBS WERE CREATED IN THE US ECONOMY, UP FROM THE PROJECTED 328,000; The US stock market has already gone from plus to minus this morning. One of the main reasons for the market slump is news that Tesla CEO Elon Musk said the leading electric car company needs to cut staff in the face of a dismal economic outlook, according to an email sent to executives and...
Continue reading >>by Market Updates and Alerts BRISTOL MYERS SQUIBB TO ACQUIRE TURNING POINT AT $76 SHARE Turning Point Therapeutics (NASDAQ: YPTX) was up 118.35% after announcing a merger agreement with Bristol Myers Squibb (NYSE: BMY). Bristol Myers Squibb will purchase Turning Point Therapeutics at $76 per share, according to the agreement terms. The Board of directors of both companies unanimously approved...
Continue reading >>FUTURES CONTRACTS TRY TO KEEP UP IN THE US, BUT STOCKS TUMBLE IN EUROPE IN THE FACE OF STRONG INFLATION AND IMPACT ON THE INDUSTRY Markets struggle to find direction. On the one hand, stocks at attractive prices encourage investors to buy. On the other hand, the signs that inflation remains firm and strong, could force central banks to adopt a more restrictive monetary policy, and add caution...
Continue reading >>EU CHOOSES SIGA’S TECOVIRIMA TO FIGHT MONKEYPOX SIGA Technologies Inc. (NASDAQ: SIGA) jumped 41.91% after the biotech announced on May 19, 2022, the approval its IV formulation of the TPOXX therapy for smallpox treatment. Another potential driver for the stock surge is the Monkeypox virus outbreak which is endemic to Africa and rare in other regions. The company and the US government...
Continue reading >>